The North America autotransfusion system market is projected to reach approximately US $550 million by 2033, growing at a CAGR of around 7.6%. Growth is fueled by increasing high-blood-loss surgeries and FDA-cleared innovations such as Haemonetics’ next-gen systems https://www.datamintelligence.com/research-report/north-america-autotransfusion-system-market